Park Medi World Limited shareholders have approved a special resolution to amend certain objects of its Initial Public Offer (IPO) proceeds. The resolution was passed via postal ballot on September 3, 2026, receiving near-unanimous support across investor categories.

The voting process concluded with 39,51,47,456 votes cast in favor of the resolution, representing 99.99% of the total votes polled. Only 3,919 votes were recorded against the proposal. The company had a total of 43,19,30,864 equity shares outstanding as of the record date, July 31, 2026.

Voting Breakdown by Investor Category

Promoter and promoter group shareholders demonstrated complete alignment with the management's proposal. The promoters hold 35,80,48,507 shares and voted 100% in favor of the resolution. Public institutional investors also showed strong support, casting 3,70,54,428 votes in favor out of 5,20,24,295 shares held, resulting in a 71.23% participation rate among this group.

Process Compliance

The postal ballot process was conducted through e-voting only, in compliance with Ministry of Corporate Affairs (MCA) circulars and Regulation 44 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Deepak Sharma of Sharma Jain & Associates served as the independent scrutinizer for the vote.

The e-voting window opened on August 5, 2026, at 9:00 am and closed on September 3, 2026, at 5:00 pm. The scrutinizer confirmed that the voting system provided by National Securities Depository Limited (NSDL) functioned securely and that all procedural requirements under Section 108 and 110 of the Companies Act, 2013, were met.

What the Numbers Show

The voting pattern reveals a distinct divergence between institutional and retail participation levels. While promoter and public institutional investors achieved high engagement rates—with promoters voting nearly all their holdings and institutions participating at over 71%—public non-institutional investors recorded a participation rate of just 0.22%. Despite this low turnout from retail shareholders, the dissenting votes originated entirely from this segment, accounting for all 3,919 negative votes cast.

The resolution is deemed passed as it secured the requisite majority. The detailed voting results and scrutinizer’s report are available on the company’s investor relations website.

Park Medi World has received board approval to incorporate a wholly-owned subsidiary as a special purpose vehicle (SPV) for its 550-bed public-private partnership hospital project in Prayagraj. The decision was taken at a board meeting on August 31, 2026.

The proposed entity will be named "Park Medicity Prayagraj Limited" or "Park Hospital Prayagraj Limited," subject to approval by the Ministry of Corporate Affairs. It will operate as a wholly-owned subsidiary, with the listed company holding 100% shareholding along with its nominees.

Incorporation details

The board approved the incorporation during a meeting that commenced at 10:00 am and concluded at 10:55 am on August 31, 2026. The initial cost of subscription is ₹0.15 crore, comprising 1,50,000 equity shares of face value ₹10 each. No governmental or regulatory approvals are required for the incorporation itself.

Project context

This corporate action follows the company’s disclosure on August 26, 2026, regarding winning the bid for the development and operation of the multi-super-speciality hospital in Prayagraj, Uttar Pradesh. The project was awarded under the PPP model by the Prayagraj Municipal Corporation.

Contract highlights

The agreement outlines a construction period of two years, after which Park Medi World will operate the facility under a 45-year lease. The key terms of the contract are summarised below.

Project scope

The contract positions Park Medi World as both the developer and long-term operator of the facility. The 45-year operation lease provides an extended operational mandate following the completion of construction. The planned investment of around ₹200 crore covers the development of the 550-bed hospital in Prayagraj.

Financial structure and government support

The project entails an investment of approximately ₹200 crore, funded through internal accruals. A significant component of this capital outlay is de-risked by state support: the Municipal Corporation of Prayagraj will reimburse ₹76.52 crore towards hospital construction. This concession covers approximately 38% of the total investment.

In consideration for the concession, Park Group will pay an annual fee of ₹18.10 crore, subject to an annual escalation of 3%.

Site details and expansion potential

The hospital will be developed on a 3.22-acre site allotted by the Municipal Corporation. The site is located directly behind Arail Ghat, approximately 3 kilometres from Sangam Ghat by road. The company holds an option to secure an additional 2.47 acres from the fifth year following the Commercial Operations Date (COD), providing headroom for future expansion.

Strategic context in Uttar Pradesh

The Prayagraj project forms part of Park Group’s broader strategy in Uttar Pradesh. Alongside its 360-bed hospital in Agra and an upcoming 400-bed facility in Gorakhpur, the company’s total capacity in the state will reach 1,260 beds upon completion. This positions the group as one of the leading private healthcare providers in the region.

Park Group currently operates 17 hospitals with a combined capacity of around 4,300 beds. With ongoing integrations and expansions, total group capacity is expected to reach approximately 6,300 beds.